Display options
Share it on

Front Oncol. 2021 Jul 14;11:698150. doi: 10.3389/fonc.2021.698150. eCollection 2021.

Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007.

Frontiers in oncology

Svenja Boekhoff, Brigitte Bison, Daniela Genzel, Maria Eveslage, Anna Otte, Carsten Friedrich, Jörg Flitsch, Hermann L Müller

Affiliations

  1. Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University, Klinikum Oldenburg AöR, Oldenburg, Germany.
  2. Department of Neuroradiology, University Hospital Würzburg, Würzburg, Germany.
  3. Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  4. Department of Neurosurgery, University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany.

PMID: 34336685 PMCID: PMC8317984 DOI: 10.3389/fonc.2021.698150

Abstract

BACKGROUND: Cerebral infarction (CI) is a known vascular complication following treatment of suprasellar tumors. Risk factors for CI, incidence rate, and long-term prognosis are unknown for patients with childhood-onset craniopharyngioma (CP).

METHODS: MRI of 244 CP patients, recruited between 2007 and 2019 in KRANIOPHARYNGEOM 2007, were reviewed for CI. Risk factors for CI and outcome after CI were analyzed.

RESULTS: Twenty-eight of 244 patients (11%) presented with CI based on reference assessment of MRI. One CI occurred before initial surgery and one case of CI occurred after release of intracystic pressure by a cyst catheter. 26 of 28 CI were detected after surgical tumor resection at a median postoperative interval of one day (range: 0.5-53 days). Vascular lesions during surgical procedures were documented in 7 cases with CI. No relevant differences with regard to surgical approaches were found. In all 12 irradiated patients, CI occurred before irradiation. Multivariable analyses showed that hydrocephalus and gross-total resection at the time of primary diagnosis/surgery both were risk factors for CI. After CI, quality of life (PEDQOL) and functional capacity (FMH) were impaired.

CONCLUSIONS: CI occurs in 11% of surgically-treated CP cases. Degree of resection and increased intracranial pressure are risk factors, which should be considered in the planning of surgical procedures for prevention of CI.

Copyright © 2021 Boekhoff, Bison, Genzel, Eveslage, Otte, Friedrich, Flitsch and Müller.

Keywords: cerebral infarction; craniopharyngioma; irradiation; quality of life; surgery

Conflict of interest statement

HM has received reimbursement of participation fees for scientific meetings and continuing medical education events from the following companies: Ferring, Lilly, Pfizer, Sandoz/Hexal, Novo Nordisk, Ip

References

  1. Int J Radiat Oncol Biol Phys. 1992;24(4):611-7 - PubMed
  2. Klin Padiatr. 2014 May;226(3):161-8 - PubMed
  3. Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):81-9 - PubMed
  4. Endocr Rev. 2006 Jun;27(4):371-97 - PubMed
  5. Eur J Endocrinol. 2019 Apr;180(4):R159-R174 - PubMed
  6. Helv Paediatr Acta Suppl. 1989 Jun;52:1-125 - PubMed
  7. Pediatr Blood Cancer. 2011 Jul 1;56(7):1120-6 - PubMed
  8. Clin Transl Radiat Oncol. 2019 Feb 07;15:93-98 - PubMed
  9. Pituitary. 2014 Apr;17(2):171-9 - PubMed
  10. Neurol Med Chir (Tokyo). 1998 Oct;38(10):666-8 - PubMed
  11. J Neurosurg. 1998 Jan;88(1):43-50 - PubMed
  12. J Neurosci Rural Pract. 2013 Jan;4(1):107-9 - PubMed
  13. Klin Padiatr. 1996 Sep-Oct;208(5):294-8 - PubMed
  14. Pituitary. 2016 Aug;19(4):422-8 - PubMed
  15. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1427-31 - PubMed
  16. Stereotact Funct Neurosurg. 1999;72 Suppl 1:132-9 - PubMed
  17. Pituitary. 2013 Mar;16(1):46-55 - PubMed
  18. Dtsch Arztebl Int. 2019 May 3;116(18):321-328 - PubMed
  19. Cancer J. 2009 Jul-Aug;15(4):298-305 - PubMed
  20. Neurosurg Focus. 2010 Apr;28(4):E14 - PubMed
  21. Endocr Rev. 2014 Jun;35(3):513-43 - PubMed
  22. J Clin Endocrinol Metab. 2011 Jul;96(7):1981-91 - PubMed
  23. Neuro Oncol. 2015 Jul;17(7):1029-38 - PubMed
  24. Eur J Endocrinol. 2011 Jul;165(1):17-24 - PubMed
  25. Klin Padiatr. 2004 Nov-Dec;216(6):343-8 - PubMed
  26. Surg Neurol. 1986 Jan;25(1):49-54 - PubMed
  27. Childs Nerv Syst. 2005 Jul;21(7):539-45 - PubMed
  28. Stroke. 1992 Jun;23(6):908-11 - PubMed
  29. Nat Rev Dis Primers. 2019 Nov 7;5(1):75 - PubMed
  30. Eur J Clin Nutr. 1991 Jan;45(1):13-21 - PubMed
  31. Klin Padiatr. 2001 Jul-Aug;213(4):244-9 - PubMed
  32. Neurol Med Chir (Tokyo). 2012;52(12):933-6 - PubMed
  33. Eur J Endocrinol. 2018 Jan;178(1):93-102 - PubMed
  34. Endocr Connect. 2019 May 1;8(5):481-492 - PubMed
  35. J Clin Endocrinol Metab. 2012 Nov;97(11):3935-43 - PubMed
  36. J Neurosurg. 1999 May;90(5):823-7 - PubMed
  37. Eur J Pediatr. 2021 May;180(5):1593-1602 - PubMed
  38. Nat Rev Endocrinol. 2017 May;13(5):299-312 - PubMed
  39. Neurology. 2007 Mar 20;68(12):932-8 - PubMed
  40. Klin Padiatr. 2004 Nov-Dec;216(6):323-30 - PubMed
  41. Cancer. 1989 Jun 15;63(12):2404-8 - PubMed
  42. Handb Clin Neurol. 2014;124:235-53 - PubMed
  43. Klin Padiatr. 2000 Jul-Aug;212(4):211-5 - PubMed
  44. Neurol Res. 1999 Dec;21(8):796-8 - PubMed

Publication Types